Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03007472 · ClinicalTrials.gov registry record · NA
Clinical Evaluation of the Cochlear Nucleus CI532 Cochlear Implant in Adults
A NA study of Hearing Loss, Sensorineural, sponsored by Cochlear.
- Completed
- Registry status
- NA
- Development phase
- 96
- Enrollment target
- 10
- Study locations
NCT03007472: Completed NA study of Hearing Loss, Sensorineural, sponsored by Cochlear.
NCT03007472 is a NA study of Hearing Loss, Sensorineural that has completed, run by Cochlear. The registered enrollment target is 96 participants, below the 781-participant average among 20 other Hearing Loss, Sensorineural trials with a reported enrollment target (88% lower). The trial reports 10 study locations across 8 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03007472, a NA study of Hearing Loss, Sensorineural, has completed, sponsored by Cochlear.
- COMPLETED
- Registry status
- NA
- Development phase
- 96 participants
- Enrollment target
- 10
- Study locations
Study Summary
The purpose of this study is to gather long-term data on the FDA approved CI532 cochlear implant, and CP1000 (Nucleus 7) sound processor
Primary Outcome
Group mean Consonant Nucleus Consonant (CNC) word recognition in quiet measured pre-operatively and again at 6 month post sound processor activation compared to the group mean score in the preoperative, best unilateral condition. The CNC word test has a score range of 0-100% with higher values indicating better scores.
Conditions Studied
Interventions
- DEVICE CI532
- DEVICE Nucleus 7
Study Locations (10)
Missouri
- The Center for Hearing and Balance Disorders - Chesterfield
- Midwest Ear Institute - Kansas City
- Washington University - St Louis
Colorado
- Rocky Mountain Ear Center - Englewood
Iowa
- University of Iowa - Iowa City
Michigan
- University of Michigan - Ann Arbor
New York
- New York University - New York
Ohio
- The Ohio State University - Columbus
Oklahoma
- Hearts for Hearing - Oklahoma City
Texas
- Dallas Ear Institute - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 96 participants |
| Start Date | 2017-02-15 |
| Est. Completion | 2020-03-06 |
| Phase | NA |
What the finished NCT03007472 record still lists
NCT03007472 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 96 participants, a relatively small participant target, below the 781-participant average among 20 other Hearing Loss, Sensorineural trials with a reported enrollment target (88% lower).
The record links to 1 condition, with Hearing Loss, Sensorineural appearing as the primary indexed condition, and to 2 interventions - of which CI532 is the first listed.
NCT03007472 lists 10 locations in 8 states (Missouri, Colorado, Iowa).
Frequently Asked Questions
What is clinical trial NCT03007472 about?
NCT03007472 is a clinical study titled "Clinical Evaluation of the Cochlear Nucleus CI532 Cochlear Implant in Adults". The purpose of this study is to gather long-term data on the FDA approved CI532 cochlear implant, and CP1000 (Nucleus 7) sound processor
What is the current status of trial NCT03007472?
This trial is currently completed. It is a NA study. The enrollment target is 96 participants. The study started on 2017-02-15. Estimated completion is 2020-03-06.
What conditions does trial NCT03007472 study?
This clinical trial studies the following conditions: Hearing Loss, Sensorineural.
What interventions are being tested in trial NCT03007472?
The interventions under investigation include: CI532 (DEVICE), Nucleus 7 (DEVICE).
Who is sponsoring clinical trial NCT03007472?
This trial is sponsored by Cochlear, which has 34 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03007472 being conducted?
This trial has 10 study locations across Colorado, Iowa, Michigan, Missouri, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hearing Loss, Sensorineural
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03007472's enrollment target sits among peer trials
96 6th of 20 higher than 15 of 20 other Hearing Loss, Sensorineural trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hearing Loss, Sensorineural trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Clinical Utility of Residual Hearing in the Cochlear Implant Ear
RECRUITING · NA
-
Barriers and Facilitators to OTC Hearing Aids Success
RECRUITING · NA
-
Preschool Hearing Screening
RECRUITING · NA
-
Listening Effort in Cochlear Implant Users
RECRUITING · NA
-
Characterizing Variability in Hearing Aid Outcomes in Among Older Adults With Alzheimer's Dementia
RECRUITING · NA
-
Reading Outcomes in Children With Vestibular Loss
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03401762 · 96 participants · NA
Wearable MCI to Reduce Muscle Co-activation in Acute and Chronic Stroke
- NCT03471260 · 96 participants · Phase 1
Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies
- NCT03549559 · 96 participants · NA
Imaging Histone Deacetylase in the Heart
- NCT03841058 · 96 participants · Phase 2
Abaloparatide vs. Placebo in Post-Menopausal Women and Abaloparatide in Men Receiving Initial Spinal Fusion Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI